Clinical trials
Hypercholesterolemia trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 9 |
| Sanofi | 5 |
| Kowa Company, Ltd. | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 3 |
| Astellas Pharma Inc | 2 |
| Kumamoto University | 2 |
| NewAmsterdam Pharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 52 |
| Dyslipidemias | 9 |
| Hyperlipidemias | 8 |
| Hyperlipoproteinemia Type II | 6 |
| Atherosclerosis | 4 |
| Coronary Artery Disease | 4 |
| Acute Coronary Syndrome | 3 |
| Brain Ischemia | 3 |
| Cardiovascular Diseases | 3 |
| Coronary Disease | 3 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.